Immunobiological efficacy and immunotoxicity of novel synthetically prepared fluoroquinolone ethyl 6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate

Add time:08/04/2019    Source:sciencedirect.com

The present study examined the cytotoxicity, anti-cancer reactivity, and immunomodulatory properties of new synthetically prepared fluoroquinolone derivative 6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate (6FN) in vitro. The cytotoxicity/toxicity studies (concentrations in the range 1–100 μM) are focused on the cervical cancer cells HeLa, murine melanoma cancer cells B16, non-cancer fibroblast NIH-3T3 cells and reconstructed human epidermis tissues EpiDerm™. The significant growth inhibition of cancer cells HeLa and B16 was detected. The cytotoxicity was mediated via apoptosis-associated with activation of caspase-9 and -3. After 72 h of treatment, the two highest 6FN concentrations (100 and 50 μM) induced toxic effect on epidermis tissue EpiDerm™, even the structural changes in tissue were observed with concentration of 100 μM. The effective induction of RAW 264.7 macrophages cell-release of pro- and anti-inflammatory TH1, TH2 and TH17 cytokines, with anti-cancer and/or anti-infection activities, respectively, has been revealed even following low-dose exposition.

We also recommend Trading Suppliers and Manufacturers of Ethyl 6-fluoro-4-oxo-1,4-dihydroquinoline-2-carboxylate (cas 16377-62-1). Pls Click Website Link as below: cas 16377-62-1 suppliers

Prev:Synthesis of the L-arginine congener L-indospicine (cas 16377-00-7) and evaluation of its interaction with nitric oxide synthase
Next:Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by PIROHEPTINE (cas 16378-21-5) and trihexyphenidyl)